Search Results - "FOSS, Joseph F."
-
1
An overview of the cannabinoid type 2 receptor system and its therapeutic potential
Published in Current opinion in anaesthesiology (01-08-2018)“…This narrative review summarizes recent insights into the role of the cannabinoid type 2 (CB2) receptor as potential therapeutic target in neuropathic pain and…”
Get full text
Journal Article -
2
Activation of mGluR1 Mediates C1q-Dependent Microglial Phagocytosis of Glutamatergic Synapses in Alzheimer’s Rodent Models
Published in Molecular neurobiology (01-08-2019)“…Microglia and complements appear to be involved in the synaptic and cognitive deficits in Alzheimer’s disease (AD), though the mechanisms remain elusive. In…”
Get full text
Journal Article -
3
Activation of cannabinoid receptor 2 attenuates mechanical allodynia and neuroinflammatory responses in a chronic post-ischemic pain model of complex regional pain syndrome type I in rats
Published in The European journal of neuroscience (01-12-2016)“…Complex regional pain syndrome type 1 (CRPS‐I) remains one of the most clinically challenging neuropathic pain syndromes and its mechanism has not been fully…”
Get full text
Journal Article -
4
Activation of CB2 receptor system restores cognitive capacity and hippocampal Sox2 expression in a transgenic mouse model of Alzheimer's disease
Published in European journal of pharmacology (15-09-2017)“…Alzheimer's disease (AD) is a neurodegenerative disorder characterized by neuroinflammation, extensive deposits of amyloid-β aggregates, and loss of memory and…”
Get full text
Journal Article -
5
Amyloid Fibril–Induced Astrocytic Glutamate Transporter Disruption Contributes to Complement C1q-Mediated Microglial Pruning of Glutamatergic Synapses
Published in Molecular neurobiology (01-05-2020)“…The complement C1q plays a critical role in microglial phagocytosis of glutamatergic synapses and in the pathogenesis of neuroinflammation in Alzheimer’s…”
Get full text
Journal Article -
6
Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial
Published in The Journal of pharmacology and experimental therapeutics (01-01-2002)“…Methylnaltrexone, the first peripheral opioid receptor antagonist, has the potential to prevent or reverse opioid-induced peripherally mediated side effects…”
Get more information
Journal Article -
7
Amyloid fibrils induce dysfunction of hippocampal glutamatergic silent synapses
Published in Hippocampus (01-08-2018)“…Silent glutamatergic synapses lacking functional AMPA (α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazoleproprionate) receptors exist in several brain regions including…”
Get full text
Journal Article -
8
Medical Use of Marijuana: Truth in Evidence
Published in Anesthesia and analgesia (01-11-2015)Get full text
Journal Article -
9
Peripherally Acting Mu-Opioid Receptor Antagonists and Postoperative Ileus: Mechanisms of Action and Clinical Applicability
Published in Anesthesia and analgesia (01-06-2009)“…Postoperative ileus (POI), a transient cessation of coordinated bowel function after surgery, is an important health care problem. The etiology of POI is…”
Get full text
Journal Article -
10
A Review of the Potential Role of Methylnaltrexone in Opioid Bowel Dysfunction
Published in The American journal of surgery (01-11-2001)“…Opioids are widely used analgesics in patients with advanced cancer. However, their effectiveness for pain relief is often limited by the most frequently…”
Get full text
Journal Article Conference Proceeding -
11
Methylnaltrexone for Reversal of Constipation Due to Chronic Methadone Use: A Randomized Controlled Trial
Published in JAMA : the journal of the American Medical Association (19-01-2000)“…CONTEXT Constipation is the most common chronic adverse effect of opioid pain medications in patients who require long-term opioid administration, such as…”
Get full text
Journal Article -
12
Are Peripheral Opioid Antagonists the Solution to Opioid Side Effects?
Published in Anesthesia and analgesia (01-01-2004)“…Opioid medication is the mainstay of therapy for severe acute and chronic pain. Unfortunately, the side effects of these medications can affect patient comfort…”
Get full text
Journal Article -
13
Development and use of methylnaltrexone, a peripherally acting opioid antagonist, to treat side effects related to opioid use
Published in Drug development research (01-09-2009)“…Opioid medications are used extensively as potent analgesics for treating moderate to severe pain. Although opioids offer reliable pain relief, their use is…”
Get full text
Journal Article -
14
Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial
Published in Clinical pharmacology and therapeutics (01-04-1996)“…Methylnaltrexone is a quaternary opioid antagonist with limited ability to cross the blood-brain barrier and the potential to antagonize the peripherally…”
Get more information
Journal Article -
15
The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time
Published in Clinical pharmacology and therapeutics (01-04-1997)“…Methylnaltrexone is a quaternary opioid antagonist with limited ability to cross the blood‐brain barrier that has the potential to antagonize the peripherally…”
Get full text
Journal Article -
16
Effects of Low-Dose Morphine on Gastric Emptying in Healthy Volunteers
Published in Journal of clinical pharmacology (01-11-1998)“…Appropriate preoperative pain therapy for patients undergoing surgery may be withheld due to the fear that opioids will inhibit gastric emptying and increase…”
Get full text
Journal Article -
17
Efficacy of orally administered methylnaltrexone in decreasing subjective effects after intravenous morphine
Published in Drug and alcohol dependence (01-10-1998)“…Opioid compounds are commonly used analgesics. After opioid administration, troublesome subjective effects, such as dysphoria, dizziness, nausea, and pruritus,…”
Get full text
Journal Article -
18
Determination of methylnaltrexone in clinical samples by solid-phase extraction and high-performance liquid chromatography for a pharmacokinetics study
Published in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (25-11-2002)“…A high-performance liquid chromatographic (HPLC) method with electrochemical detection and solid-phase extraction (SPE) using cartridges of weak…”
Get full text
Journal Article -
19
Antagonism of gastrointestinal opioid effects
Published in Regional anesthesia and pain medicine (01-11-2000)Get full text
Journal Article -
20
Antagonism of Gastrointestinal Opioid Effects
Published in Regional anesthesia and pain medicine (01-11-2000)Get full text
Journal Article